Potential new treatments for pulmonary fibrosis: The Clinical Trial Innovation Series

In this special presentation, learn about potential new treatments for pulmonary fibrosis and interstitial lung disease that are currently in the pipeline. The clinical trials discussed in this session are listed below.
Avalyn Pharma: ATLAS Study & MIST Study
Bristol-Myers Squibb: ALOFT-IPF Study & ALOFT-PPF Study
GlaxoSmithKline (GSK): TRANSFORM Study & BEconneCTD-ILD Study
Participation in the CTI Webinar Series and references to specific commercial entities (companies) or products do not reflect endorsement by the PFF. The PFF does not endorse or promote any products or services participants discuss in the CTI Webinar Series, and participants cannot suggest otherwise. Please note that any information contained in this presentation is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider to determine if a clinical trial is right for you.